According to a Hong Kong Stock Exchange announcement, Huajian Medical, a Hong Kong-listed company, disclosed in mid-August that it had announced a potential major acquisition plan to acquire cryptocurrency for no more than RMB 3 billion and was preparing to submit it to shareholders for approval. However, it failed to send a circular to shareholders as scheduled, and two and a half months later, there has been no progress. Huajian Medical stated that due to the need for additional time to obtain shareholder authorization, it has temporarily suspended the major acquisition. If it continues to purchase ETH (Ethereum) in the market in the future, it will disclose the transaction in accordance with the Hong Kong Stock Exchange Listing Rules, especially Chapter 14, which requires public disclosure.